Clinical trial
A Prospective, Randomized, Controlled, Multi-Center Study to Evaluate the Safety and Effectiveness of the Episealer® Knee System Compared to Microfracture for the Treatment of Focal Femoral Knee Chondral or Osteochondral Lesions
NCT04000659 is registered in ClinicalTrials.gov with Episurf Medical Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Randomized, Controlled, Multi-Center Study to Evaluate the Safety and Effectiveness of the Episealer® Knee System Compared to Microfracture for the Treatment of Focal Femoral Knee Chondral or Osteochondral Lesions
- Lead sponsor
- Episurf Medical Inc.
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- June 18, 2020
- Completion date
- June 30, 2029
- Enrollment
- 13 (actual)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.
degenerative lesion of articular cartilage of knee